Regulus Therapeutics Inc. 4
4 · Regulus Therapeutics Inc. · Filed Oct 5, 2016
Insider Transaction Report
Form 4
WRIGHT TIMOTHY MICHAEL
Chief R & D Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-10-03+450,000→ 450,000 totalExercise: $3.30Exp: 2026-10-02→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]25% of the shares vest on October 3, 2017 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on October 2, 2021.